Market revenue in 2024 | USD 160.3 million |
Market revenue in 2030 | USD 221.2 million |
Growth rate | 5.5% (CAGR from 2024 to 2030) |
Largest segment | Defibrillators |
Fastest growing segment | Defibrillators |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT) |
Key market players worldwide | Stryker Corp, BIOTRONIK, SCHILLER, Medtronic PLC, Abbott Laboratories, Koninklijke Philips NV, ZOLL Medical Corporation, Boston Scientific Corp, LivaNova PLC, Progetti Medical |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cardiac rhythm management devices market will help companies and investors design strategic landscapes.
Defibrillators was the largest segment with a revenue share of 51.78% in 2024. Horizon Databook has segmented the Saudi Arabia cardiac rhythm management devices market based on pacemakers, defibrillators, cardiac resynchronization therapy (crt) covering the revenue growth of each sub-segment from 2018 to 2030.
The growing awareness about cardiac health and demand for quality healthcare services is expected to drive the market in the future. For instance, in April 2023, The Saudi Red Crescent Authority (SRCA) announced to installation of AEDs in mosques within the Riyadh region.
These factors are contributing to the CRMDs market growth. Atrial fibrillation is a key driver of the cardiac rhythm management devices market in Saudi Arabia due to its high prevalence, associated complications, advancements in treatment options, increasing awareness, and government support for healthcare initiatives.
These factors contribute to the growing demand for CRM devices used in the management of AF in Saudi Arabia. According to an article published by NIH in 2018, the study found that the rate of atrial fibrillation among Saudi Arabian patients with chronic heart failure was 14.9%.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia cardiac rhythm management devices market, including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia cardiac rhythm management devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account